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Aggressive angiomyxoma in the ischiorectal fossa
Asra Wahid,1 Abdul Hakeem,2 Sadaf Khan3

Abstract
Aggressive Angiomyxoma (AA) is a soft tissue tumour that
principally affects women of the reproductive age,
primarily involving the pelvis and the perineum. Despite
being slow growing, it is classified as aggressive due to its
locally infiltrative nature and high recurrence. It is rare,
often asymptomatic and is misdiagnosed. However, it has
characteristic features on radiographic imaging.
Complete surgical resection is the ideal approach to treat
AA. We report a case of an aggressive angiomyxoma in a
17 year old female, located in the ischiorectal fossa and
diagnosed incidentally on a magnetic resonance imaging
(MRI). The lesion was excised without complication.
Keywords: Aggressive angiomyxoma, Mesenchymal
neoplasm, Perineal tumour.
DOI: https://doi.org/10.5455/JPMA.30242

Introduction
Aggressive angiomyxoma is a slow growing
mesenchymal neoplasm.1 It arises primarily in the deep
soft tissues of the pelvis, perineum of the reproductive
age women and in the inguinoscrotal region in the men.
The tumour has a locally infiltrative nature. It has a high
rate of local recurrence (70%) but lacks metastatic
potential.2,3 Clinically, patients are often asymptomatic
and may be misdiagnosed. The tumour is usually large
(>10cm) and is discovered during pelvic examination or
on a radiographic imaging.1,4,5 It has a lobulated
appearance with a soft rubbery consistency and may
infiltrate into surrounding tissues.3 On magnetic
resonance imaging (MRI), it has a characteristic internal
low intensity swirled appearance on both T1 and T2
weighted images.4 Histologic examination reveals a
sparsely cellular tumour consisting of spindle and stellateshaped cells in a myxoid background studded with blood
vessels.2 Treatment modality includes a wide local
surgical excision with a long term follow-up.3,6 We report
a case of a 17-year-old female being evaluated for a year

long history of lower back pain who was incidentally
found to have a mass in the ischiorectal fossa on a MRI. It
is unique, because it is a rare and slowly progressing
disease with vague symptoms, difficult diagnosis and no
definite treatment guidelines. In our case, a successful
complete surgical resection with clear margins was
performed which is generally the preferred treatment.
This could add to the literature of successful cases and can
potentially help define treatment in the future. Informed
consent was taken from the patient for writing the report.

Case Presentation
A 17-year-old female with an unremarkable medical and
surgical history presented to the clinic with lower back
pain. It was associated with a burning sensation localized
to the lower back along with numbness radiating to the
legs. Clinical examination was unremarkable. She was
managed conservatively with analgesics and muscle
relaxants but had persistent symptoms, she presented
first time at Aga Khan University Hospital, Karachi on 8th
August 2017.
A pelvic MRI was obtained, which did not identify any
spinal pathology. However, it showed a 1.9 x 2.1 cm welldefined rounded lesion in the right ischiorectal fossa
closely abutting right obturator internus with an intact fat
planes laterally and anteromedially, extending to the
levatorani muscle. The lesion was hypointense on T1 and
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Figure-1: View of the structures within the perianal region before excision of the
tumour.
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were consistent with an aggressive angiomyxoma.
Immunohistochemistry showed positive desmin, CD 34
and ER signals while S-100 and an alpha smooth muscle
actin (α - SMA) were negative.
No post-surgery complications were seen; wound site was
managed with dressing and stitches were removed within
2 weeks. Patient complained of constipation
postoperatively for 2 weeks which responded to
medications and dietary manipulation. Follow up scan
after 6 and 12 months revealed no recurrence of the
disease.

Discussion

Figure-2: Gross examination of the excised tumour.

hyperintense on T2-weighted images, with subtle postcontrast enhancement. She was referred for surgical
evaluation 5 months after her initial MRI and was advised
a repeat MRI. It revealed an increase in the size (4 x 3 cm)
of the lesion. Differential diagnosis after a repeat MRI
included a lipoma and a liposarcoma. A computed
tomography (CT) scan guided core biopsy was suggestive
of an aggressive angiomyxoma. A decision for surgical
excision was made.
Bowel was prepared with rectal enemas. After the
administration of general anaesthesia, patient was placed
in a prone-jackknife position. A 6cm crescent incision was
placed over the right ischiorectal fossa. Dissection was
continued proximally into the space using electrocautery
as shown in Figure-1. With help of a manual palpation, the
lesion was identified and sharply dissected and care was
taken not to breach the capsule. The lesion was well
circumscribed without any signs of surrounding
infiltration or extension into the rectum medially or in the
levatorani superiorly. On excision, the lesion was noted to
be soft with a smooth surface, measuring 7 x 4.5 x 2 cm
(Figure-2).
On histopathology, the cut surface was grey-white.
Microscopic examination revealed a neoplastic lesion
comprising of haphazard arrangement of spindle shaped
cells in a myxoid background. Individual cells had
elongated vesicular nuclei, inconspicuous nucleoli, scant
eosinophilic cytoplasm and interspersed thin strands of
collagen. Vessels showed adventitial thickening with
perivascular lymphocytic cuffing with presence of smooth
muscle cells. Occasional mitotic figures were seen but
necrosis was absent. The tumour's histological features
J Pak Med Assoc

Aggressive Angiomyxoma (AA), a slow growing and
benign mesenchymal tumour occurs in women in their
40s and 50s.2,4 It usually occurs in the female pelvis and
the perineum especially, the vulva. We the report a case of
a 17-year-old female in the ischiorectal fossa. In men, AA
is rarely reported, usually involving the inguinoscrotal
region. Male to female ratio is 1:6.6.3 In a study reported
from Pakistan, it was seen to comprise of 10% of the
benign tumours of the vulva.7
AA usually causes displacement of adjacent organs
typically without invasion. However, due to its locally
infiltrative and aggressive nature it can cause invasion
during longstanding growth.6 These tumours have a high
rate of local recurrence varying from 36-70%, usually
within the first two years. However, it is treated by reexcision with a 1cm margin.1,6
Patients are often asymptomatic or present with a
painless mass. However, our patient had a year long
history of nonspecific back pain which had resolved by
the time she came for the surgery. Due to their location,
AAs are usually large and measure more than 10 cm at the
time of the diagnosis. Frequently the large, deep seated
pelvic component of the aggressive angiomyxomas in
relation to the pelvic diaphragm is not appreciated on
clinical examination and can often be missed.8
Clinically, differential diagnosis of AA includes myxoma,
myxoid liposarcoma, pelvic fibromatosis, levator hernia,
bartholin cyst, labial cyst, gartner duct cyst or lipoma.1,5
The main histologic differential consideration would be
an angiomyofibroblastoma.
Imaging modalities that assist with diagnosis include CT
scan, MRI and pelvic digital subtraction angiography
(DSA).9 Sonographic imaging shows a hypoechoic or a
cystic mass.4 Angiography typically shows a hyper
vascular mass.9 On CT scan, the tumour has a distinct
border with minimal hypodensity compared to muscle.
On MRI, both T1-weighted and T2-weighted images, mass
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has areas of "swirled" linear low-intensity signal
suggesting a fibrovascular stroma. On T1-weighted
images, the tumour is isointense compared to a muscle.
T2-weighted images show a hyperintense tumour due to
high water content and loose myxoid matrix. In our
patient, we report similar findings on a MRI.4
On gross assessment, tumours are usually not
encapsulated and have sharp margination in some areas
while blending gradually with surrounding soft tissue in
others. Areas of congested blood vessels, haemorrhage or
fibrosis may be present.9 Our patient's tumour had a
similar appearance (Figure-2), on inspection it was a
pink/gray mass with a rubbery texture and a gelatinous
glistening cut surface. Microscopic findings in our patient
are consistent with those reported in the literature.
Resection margins are usually positive due to the
tumour's tendency to infiltrate local tissues. Almost all AA
on immunohistochemistry show positive vimentin and
desmin signals with a negative S-100 signals. The positive
rates of CD34, smooth muscle actin (SMA), a-SMA,
oestrogen receptor (ER) or progesterone receptor (PR)
have been reported many times in the literature4. We
report positive desmin, CD 34, ER signals along with a
negative S-100 and a-SMA signals. Recent molecular
assessments indicate that certain genetic alterations
appear to have a role in the pathogenesis of this tumour
and may be useful markers for microscopic residual
disease.
Complete surgical resection of the lesion must be
considered, as done in our case. Partial resection is
considered when a high surgical morbidity or a mutilating
surgery is anticipated. This can be bolstered with adjunct
therapies, including arterial embolization, hormonal
treatment or radiotherapy.10
There are no definite guidelines on the postoperative
management of AA. Since the recurrence rate is as high
as 72% and undiagnosed occurrences are associated with
morbidity, various authors have recommend periodic
assessment comprising of physical examination and a MRI
after the surgical resection. Follow-up for up to 15 years
has been described.10 At 1 year our patient showed no
evidence of recurrent disease. A definite prognosis of this
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would require a long term follow up, which is a limitation
in this report.

Conclusion
Angiomyxoma is a rare tumour that is often missed due to
an unremarkable clinical examination. It is common in
women of mid-30s, however, it can also present in
teenagers, as in our case. No definite guidelines exist
regarding its management but complete surgical
resection is the key treatment. However, regular long
follow-ups are needed to assess the recurrence.
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